TECHNETIUM TC 99M SULFUR COLLOID
Pre-Launchtechnetium tc-99m sulfur colloid
NDAORALSOLUTION
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Technetium Tc-99m Sulfur Colloid is a radiopharmaceutical diagnostic agent used for nuclear medicine imaging. It is administered orally as a solution and localizes in the reticuloendothelial system to visualize organ function and blood flow. This agent enables visualization of the liver, spleen, bone marrow, and gastroesophageal tract.
Pre-Launch
Pre-launch phase suggests small commercial team; career opportunity lies in building launch infrastructure and establishing market access.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on this product in pre-launch phase offers career opportunity to build commercial infrastructure from the ground up and shape market entry strategy for a diagnostic radiopharmaceutical. Roles will emphasize regulatory navigation, manufacturing partnerships, and establishing diagnostic imaging market access.
Regulatory Affairs SpecialistMedical Science Liaison
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.